Roles of porphyrin and iron metabolisms in the δ-Aminolevulinic acid (ALA)-induced accumulation of protoporphyrin and photodamage of tumor cells

Photochemistry and Photobiology

Volumn 87, Issue 5, 2011, Pages 1138-1145

  Ohgari, Yoshiko ^a   Miyata, Yoshinobu ^a   Miyagi, Taeko ^a   Gotoh, Saki ^a   Ohta, Takano ^a   Kataoka, Takao ^a   Furuyama, Kazumichi ^b   Taketani, Shigeru ^a  

^a KYOTO INSTITUTE OF TECHNOLOGY   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; CATION TRANSPORT PROTEIN; HEME; HEME OXYGENASE; HEME OXYGENASE 1; HEME OXYGENASE 2; HEME OXYGENASE-2; IRON; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN; SLC25A28 PROTEIN, HUMAN; SMALL INTERFERING RNA;

ARTICLE; BIOSYNTHESIS; CELL SURVIVAL; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; GENE SILENCING; GENETIC TRANSFECTION; GENETICS; HELA CELL; HUMAN; LIGHT; METABOLISM; MITOCHONDRION; PATHOLOGY; PHOTOCHEMOTHERAPY; PLASMID; RADIATION EXPOSURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERINE CERVIX TUMOR;

AMINOLEVULINIC ACID; CATION TRANSPORT PROTEINS; CELL SURVIVAL; FEMALE; GENE SILENCING; HELA CELLS; HEME; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; HUMANS; IRON; LIGHT; MITOCHONDRIA; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PLASMIDS; PROTOPORPHYRINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSFECTION; UTERINE CERVICAL NEOPLASMS;

EID: 80052399645     PISSN: 00318655     EISSN: 17511097     Source Type: Journal    
DOI: 10.1111/j.1751-1097.2011.00950.x     Document Type: Article

References (41)

1. Dougherty, T. J., C. J. Gomer, B. W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan, and, Q. Peng, (1998) Photodynamic therapy. J. Natl. Cancer Inst. 90, 889-905.
2. De Rosa, F. S., R. F. Lopez, J. A. Thomazine, A. C. Tedesco, N. Lange, and, M. Bentley, (2004) In vitro metabolism of 5-ALA esters derivatives in hairless mice skin homogenate and in vivo PpIX accumulation studies. Pharm. Res. 21, 2247-2252.
3. Fischer, F., E. F. Dickson, J. C. Kennedy, and, R. H. Pottier, (2001) An affordable, portable fluorescence imaging device for skin lesion detection using a dual wavelength approach for image contrast enhancement and aminolaevulinic acid-induced protoporphyrin IX. Part II. In vivo testing. Lasers Med. Sci. 16, 207-212.
4. Fischer, F., E. F. Dickson, R. H. Pottier, and, H. Wieland, (2001) An affordable, portable fluorescence imaging device for skin lesion detection using a dual wavelength approach for image contrast enhancement and aminolaevulinic acid-induced protoporphyrin IX. Part I. Design, spectral and spatial characteristics. Lasers Med. Sci. 16, 199-206.
5. Hirschberg, H., F. A. Uzal, D. Chighvinadze, M. J. Zhang, Q. Peng, and, S. J. Madsen, (2008) Disruption of the blood-brain barrier following ALA-mediated photodynamic therapy. Lasers Surg. Med. 40, 535-542.
6. Furuyama, K., K. Kaneko, and, P. D. Vargas, (2007) Heme as a magnificent molecule with multiple missions: heme determines its own fate and governs cellular homeostasis. Tohoku J. Exp. Med. 213, 1-16.
7. Yamamoto, F., Y. Ohgari, N. Yamaki, S. Kitajima, O. Shimokawa, H. Matsui, and, S. Taketani, (2007) The role of nitric oxide in delta-aminolevulinic acid (ALA)-induced photosensitivity of cancerous cells. Biochem. Biophys. Res. Commun. 353, 541-546.
8. Ohgari, Y., Y. Nakayasu, S. Kitajima, M. Sawamoto, H. Mori, O. Shimokawa, H. Matsui, and, S. Taketani, (2005) Mechanisms involved in delta-aminolevulinic acid (ALA)-induced photosensitivity of tumor cells: relation of ferrochelatase and uptake of ALA to the accumulation of protoporphyrin. Biochem. Pharmacol. 71, 42-49.
9. Taketani, S., (2005) Aquisition, mobilization and utilization of cellular iron and heme: endless findings and growing evidence of tight regulation. Tohoku J. Exp. Med. 205, 297-318.
10. Andoh, Y., H. Suzuki, M. Araki, A. Mizutani, T. Ohashi, T. Okumura, Y. Adachi, S. Ikehara, and, S. Taketani, (2004) Low- and high-level expressions of heme oxygenase-1 in cultured cells under uninduced conditions. Biochem. Biophys. Res. Commun. 320, 722-729.
11. Ryter, S. W., and, A. M. Choi, (2009) Heme oxygenase-1/carbon monoxide: from metabolism to molecular therapy. Am. J. Respir. Cell Mol. Biol. 41, 251-260.
12. Jansen, T., M. Hortmann, M. Oelze, B. Opitz, S. Steven, R. Schell, M. Knorr, S. Karbach, S. Schuhmacher, P. Wenzel, T. Münzel, and, A. Daiber, (2010) Conversion of biliverdin to bilirubin by biliverdin reductase contributes to endothelial cell protection by heme oxygenase-1-evidence for direct and indirect antioxidant actions of bilirubin. J. Mol. Cell. Cardiol. 49, 186-195.
13. Miyake, M., M. Ishii, K. Kawashima, T. Kodama, K. Sugano, K. Fujimoto, and, Y. Hirao, (2009) siRNA-mediated knockdown of the heme synthesis and degradation pathways: modulation of treatment effect of 5-aminolevulinic acid-based photodynamic therapy in urothelial cancer cell lines. Photochem. Photobiol. 85, 1020-1027.
14. Frank, J., M. R. Lornejad-Schäfer, H. Schöffl, A. Flaccus, C. Lambert, and, H. K. Biesalski, (2007) Inhibition of heme oxygenase-1 increases responsiveness of melanoma cells to ALA-based photodynamic therapy. Int. J. Oncol. 31, 1539-1545.
15. Modica-Napolitano, J. S., M. Kulawiec, and, K. K. Singh, (2007) Mitochondria and human cancer. Curr. Mol. Med. 7, 121-131.
16. Paradkar, P. N., K. B. Zumbrennen, B. H. Paw, D. M. Ward, and, J. Kaplan, (2009) Regulation of mitochondrial iron import through differential turnover of mitoferrin 1 and mitoferrin 2. Mol. Cell. Biol. 29, 1007-1016.
17. Schoenfeld, R. A., E. Napoli, A. Wong, S. Zhan, L. Reutenauer, D. Morin, A. R. Buckpitt, F. Taroni, B. Lonnerdal, M. Ristow, H. Puccio, and, G. A. Cortopassi, (2005) Frataxin deficiency alters heme pathway transcripts and decreases mitochondrial heme metabolites in mammalian cells. Hum. Mol. Genet. 15, 3787-3799.
18. Thierbach, R., T. J. Schulz, F. Isken, A. Voigt, B. Mietzner, G. Drewes, J. C. von Kleist-Retzow, R. J. Wiesner, M. A. Magnuson, H. Puccio, A. F. Pfeiffer, P. Steinberg, and, M. Ristow, (2005) Targeted disruption of hepatic frataxin expression causes impaired mitochondrial function, decreased life span and tumor growth in mice. Hum. Mol. Genet. 14, 3857-3864.
19. Inoue, K., T. Karashima, M. Kamada, T. Shuin, A. Kurabayashi, M. Furihata, H. Fujita, K. Utsumi, and, J. Sasaki, (2009) Regulation of 5-aminolevulinic acid-mediated protoporphyrin IX accumulation in human urothelial carcinomas. Pathobiology 76, 303-314.
20. Choudry, K., R. C. Brooke, W. Farrar, and, L. E. Rhodes, (2003) The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy. Br. J. Dermatol. 149, 124-130.
21. Taketani, S., T. Furukawa, and, K. Furuyama, (2001) Expression of coproporphyrinogen oxidase and synthesis of hemoglobin in human erythroleukemia K562 cells. Eur. J. Biochem. 268, 1705-1711.
22. Nishimura, K., S. Taketani, and, H. Inokuchi, (1995) Cloning of a human cDNA for protoporphyrinogen oxidase by complementation in vivo of a hemG mutant of Escherichia coli. J. Biol. Chem. 270, 8076-8080.
23. Vargas, P. D., K. Furuyama, S. Sassa, and, S. Shibahara, (2008) Hypoxia decreases the expression of the two enzymes responsible for producing linear and cyclic tetrapyrroles in the heme biosynthetic pathway. FEBS J. 275, 5947-5959.
24. Yoshida, T., P. Biro, T. Cohen, R. M. Müller, and, S. Shibahara, (1988) Human heme oxygenase cDNA and induction of its mRNA by hemin. Eur. J. Biochem. 171, 457-461.
25. Shibahara, S., M. Yoshizawa, H. Suzuki, K. Takeda, K. Meguro, and, K. Endo, (1993) Functional analysis of cDNAs for two types of human heme oxygenase and evidence for their separate regulation. J. Biochem. 113, 214-218.
26. Sakaino, M., T. Kataoka, and, S. Taketani, (2009) Post-transcriptional regulation of the expression of ferrochelatase by its variant mRNA. J. Biochem. 145, 733-738.
27. Ohgari, Y., Y. Miyata, T. T. Chau, S. Kitajima, Y. Adachi, and, S. Taketani, (2011) Quinolone compounds enhance delta-aminolevulinic acid-induced accumulation of protoporphyrin IX and photosensitivity of tumour cells. J. Biochem. 149, 153-160.
28. Masuya, Y., K. Hioki, R. Tokunaga, and, S. Taketani, (1998) Involvement of the tyrosine phosphorylation pathway in induction of human heme oxygenase-1 by hemin, sodium arsenite, and cadmium chloride. J. Biochem. 124, 628-633.
29. Harada, H., R. Sugimoto, A. Watanabe, S. Taketani, K. Okada, E. Warabi, R. Siow, K. Itoh, M. Yamamoto, and, T. Ishii, (2008) Differential roles for Nrf2 and AP-1 in upregulation of HO-1 expression by arsenite in murine embryonic fibroblasts. Free Radic. Res. 42, 297-304.
30. Teng, L., M. Nakada, S. G. Zhao, Y. Endo, N. Furuyama, E. Nambu, I. V. Pyko, Y. Hayashi, and, J. I. Hamada, (2011) Silencing of ferrochelatase enhances 5-aminolevulinic acid-based fluorescence and photodynamic therapy efficacy. Br. J. Cancer 104, 798-807.
31. Yasui, Y., S. Muranaka, T. Tahara, R. Shimizu, S. Watanabe, Y. Horie, E. Nanba, H. Uezato, A. Takamiyagi, S. Taketani, and, R. Akagi, (2002) A new ferrochelatase mutation combined with low expression alleles in a Japanese patient with erythropoietic protoporphyria. Clin. Sci. (Lond). 102, 501-506.
32. Anand, S., G. Honari, T. Hasan, P. Elson, and, E. V. Maytin, (2009) Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo. Clin. Cancer Res. 15, 3333-3343.
33. Sinha, A. K., S. Anand, B. J. Ortel, Y. Chang, Z. Mai, T. Hasan, and, E. V. Maytin, (2006) Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells. Br. J. Cancer 95, 485-495.
34. Hinnen, P., F. W. de Rooij, E. M. Terlouw, A. Edixhoven, H. van Dekken, R. van Hillegersberg, H. W. Tilanus, J. H. Wilson, and, P. D. Siersema, (2000) Porphyrin biosynthesis in human Barrett's oesophagus and adenocarcinoma after ingestion of 5-aminolaevulinic acid. Br. J. Cancer 83, 539-543.
35. Krieg, R. C., H. Messmann, J. Rauch, S. Seeger, and, R. Knuechel, (2002) Metabolic characterization of tumor cell-specific protoporphyrin IX accumulation after exposure to 5-aminolevulinic acid in human colonic cells. Photochem. Photobiol. 76, 518-525.
36. Grinblat, B., N. Pour, and, Z. Malik, (2006) Regulation of porphyrin synthesis and photodynamic therapy in heavy metal intoxication. J. Environ. Pathol. Toxicol. Oncol. 25, 145-158.
37. Feuerstein, T., A. Schauder, and, Z. Malik, (2009) Silencing of ALA dehydratase affects ALA-photodynamic therapy efficacy in K562 erythroleukemic cells. Photochem. Photobiol. Sci. 8, 1461-1466.
38. Krieg, R. C., S. Fickweiler, O. S. Wolfbeis, and, R. Knuechel, (2000) Cell-type specific protoporphyrin IX metabolism in human bladder cancer in vitro. Photochem. Photobiol. 72, 226-233.
39. Stemmler, T. L., E. Lesuisse, D. Pain, and, A. Dancis, (2010) Frataxin and mitochondrial FeS cluster biogenesis. J. Biol. Chem. 285, 26737-26743.
40. Schulz, T. J., R. Thierbach, A. Voigt, G. Drewes, B. Mietzner, P. Steinberg, A. F. Pfeiffer, and, M. Ristow, (2006) Induction of oxidative metabolism by mitochondrial frataxin inhibits cancer growth: Otto Warburg revisited. J. Biol. Chem. 281, 977-978.
41. Taketani, S., Y. Adachi, and, Y. Nakahashi, (2000) Regulation of the expression of human ferrochelatase by intracellular iron levels. Eur. J. Biochem. 267, 4685-4692.